News Introduction

Research and development of 3,4-dihydroxybenzaldehyde(cas 139-85-5)

Date : 2016/8/16 14:13:47

Shanxi Jin-jin Chemical Co.,Ltd is one of the pharmaceutical industries that produce 3,4-dihydroxybenzaldehyde(cas 139-85-5). In the pharmaceutical industry, in 1998 the country has more than 4,000 pharmaceutical manufacturers, to create 108 billion yuan output value, profits and taxes 13 billion. Among them, chemical production enterprises 1483, can produce 24 categories over 1500 kinds of chemicals, production was 335 000 t, the output value of 56.709 billion yuan. This reflects the rapid development of China's national industry and the reform and opening up has brought great situation. However, compared with the world pharmaceutical market, there is a big gap. In 1998 the world pharmaceutical market sales of $ 259 billion, of which 25 largest pharmaceutical companies accounted for 48% share of their drugs margin of about 30%. Whether or from the margins in terms of China's pharmaceutical industry and the world a far cry from the level of output. The reason is that our medicines to imitation, often low-level redundant, lack of innovation. So far our country in the world, there are only a handful of proprietary drugs.
In summary, it is believed, the fundamental task of China's pharmaceutical(such as 3,4-dihydroxybenzaldehyde(cas 139-85-5)) industry in the future development strategy: to practice with the international phase, to catch up with the advanced world level, must come out from the imitation, the development of new drugs with our own intellectual property rights, especially in the middle Research and development is the foundation of the body; cross-disciplinary, multi-faceted, Gao starting point to seize new growth point, hatch them as foster productivity; build engineering centers, scientific research base, create more technology platform for the new born.